Y-Intercept (HK)’s ProKidney PROK Stock Holding History

Y-Intercept (HK)’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-351,622	Closed	-$208K	–	1941
2025 Q2	$208K	Buy	+351,622	New	+$274K	0.01%	1454

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Y-Intercept (HK)'s PROK Position: Q3 2025 in Review

Y-Intercept (HK) sold out of ProKidney (PROK) in Q3 2025, closing a stake of 351,622 shares — an estimated $208K sold.

Y-Intercept (HK) first reported a position in PROK in Q2 2025 and held it in 1 quarter. The position peaked at $208K in Q2 2025. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

Y-Intercept (HK) reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 351,622 ProKidney shares in Q3 2025, an estimated $208K.
Y-Intercept (HK) first reported a position in ProKidney in Q2 2025 and held it in 1 quarter.
Y-Intercept (HK)'s ProKidney position peaked at $208K in Q2 2025.
56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.